Sen. Wyden urges FDA to issue ‘discretion policy,’ interim rule on CBD in dietary supplements

A U.S. senator characterized as “fully unacceptable” a suggestion by FDA that publishing a final rule authorizing the use of hemp-derived CBD in dietary supplements could take three to five years.